ELN Recommendations - Patient-friendly summary (2009 version, outdated)
This is outdated!Please note this is the patient-friendly summary of the 2009 version of the ELN CML Treatment Recommendation. This version is outdated and has been replaced by our summary of the European LeukemiaNET's CML Treatment Recommendations of 2013. You find the most up to date summary here: http://www.cmladvocates.net/cmlsummary We are keeping these recommendations just as a reference, but please use the newer summary instrad. |
To improve the information available to patients, an international CML workgroup of patient organisations and experts have developed a patient-friendly summary of recommendations for CML management. The original recommendations for physicians were published by CML experts on behalf of the European LeukemiaNet (ELN) in the Journal of Clinical Oncology in 2009.
While treatment guidelines and recommendations are recognised as being the standard of care by haematologists, they can be difficult for patients to understand. Thanks to a great community effort, the summary is now available in nine languages: English, French, Spanish, German, Italian, Macedonian, Polish, Serbian and Hungarian! Select the language of your choice!
Available translations:
The English, Spanish and German language versions were produced by a workgroup of patient advocates and CML experts that received support through in-kind resources from Bristol-Myers Squibb.
The other language versions were translated by patient advocates independently with support by hematologists in the respective countries. Our special thanks go to:
|
![]() |